nor-NOHA (acetate) (Synonyms: Nω-hydroxy-nor-Arginine) |
| Catalog No.GC10628 |
nor-NOHA (acetate) (alpha-amino acid N(omega) -Hydroxy-Nor-L-arginine) is a potent and reversible selective arginase inhibitor,
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1140844-63-8
Sample solution is provided at 25 µL, 10mM.
nor-NOHA (acetate) (alpha-amino acid N(omega) -Hydroxy-Nor-L-arginine) is a potent and reversible selective arginase inhibitor, nor-NOHA (acetate) is about 40-fold more potent than NOHA to inhibit the hydrolysis of l-arginine to l-ornithine catalyzed by unstimulated murine macrophages (nor-NOHA IC(50) values 12 ±5µM[4].
nor-NOHA (acetate) effectively induced apoptosis in ARG2-expressing cells under hypoxia but not normoxia. Co-treatment with nor-NOHA (acetate) overcame hypoxia-mediated resistance towards BCR-ABL1 kinase inhibitors. its anti-leukemic activity was independent of ARG2 inhibition. nor-NOHA (acetate) has significant but off-target anti-leukemic activity among ARG2-expressing hypoxic cells[3]. nor-NOHA (acetate) could inhibit the proliferation and induce the apoptosis of HepG2 cells. nor-NOHA (acetate) inhibited the invasion and migration of HepG2 cells. These data indicated that nor-NOHA (acetate) could induce cell apoptosis and inhibit the ability of invasion and migration of HepG2 cells by inhibiting Arg1[1].Supplementation of nor-NOHA (acetate) in BMEC(bovine mammary epithelial cells) reduced cellular proliferation and casein synthesis. Addition of Arg to nor-NOHA (acetate) resulted in cellular proliferation and casein synthesis similar to that of nor-NOHA (acetate) alone. In contrast, addition of Orn to the medium with nor-NOHA (acetate) increased the synthesis of casein and cellular proliferation compared with nor-NOHA (acetate) [6].
nor-NOHA (acetate) treatment could fully restore the aortic response to Ach to that of healthy rats.Such beneficial effect was mediated by an increase in NOS activity and EDHF and reduced superoxide anion production, nor-NOHA (acetate) inhibited arginase activity in aorta with IC50 less than 1 µm [2].In Chinese Holstein cows .The activity of enzymes related to Arg metabolism, milk protein synthesis, and expression of AA transporters was determined. The infusion of nor-NOHA (acetate) decreased the activity of arginase. In addition, the infusion of nor-NOHA (acetate) also reduced protein and fat synthesis in milk but had no effect on milk yield[5].Hyperthyroidism in rats is associated with the increased expression and activity of arginase in aorta, heart, and kidney. Chronic arginase inhibition with nor-NOHA (acetate) suppresses the characteristic hemodynamic manifestations of hyperthyroidism in association with a reduced oxidative stress[7].
References:
[1]: Li X, Zhu F, et,al. [Arginase inhibitor nor-NOHA induces apoptosis and inhibits invasion and migration of HepG2 cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Apr;33(4):477-482. Chinese. PMID: 28395717.
[2]: Prati C, Berthelot A, et,al. Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis. Arthritis Res Ther. 2012 May 30;14(3):R130. doi: 10.1186/ar3860. PMID: 22647483; PMCID: PMC3446511.
[3]: Ng KP, Manjeri A, et,al. The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target. PLoS One. 2018 Oct 11;13(10):e0205254. doi: 10.1371/journal.pone.0205254. PMID: 30307989; PMCID: PMC6181325.
[4]: Tenu JP, Lepoivre M, et,al. Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide. 1999 Dec;3(6):427-38. doi: 10.1006/niox.1999.0255. PMID: 10637120.
[5]: Ding LY, Chen LM, et,al.Inhibition of arginase via jugular infusion of Nω-hydroxy-nor-l-arginine inhibits casein synthesis in lactating dairy cows. J Dairy Sci. 2018 Apr;101(4):3514-3523. doi: 10.3168/jds.2017-13178. Epub 2018 Feb 4. PMID: 29397169.
[6]: Wang MZ, Ding LY, et,al. Short communication: Arginase inhibition reduces the synthesis of casein in bovine mammary epithelial cells. J Dairy Sci. 2017 May;100(5):4128-4133. doi: 10.3168/jds.2016-11823. Epub 2017 Feb 23. PMID: 28237582.
[7]: RodrÍguez-GÓmez I, Manuel Moreno J, et,al. Effects of Arginase Inhibition in Hypertensive Hyperthyroid Rats. Am J Hypertens. 2015 Dec;28(12):1464-72. doi: 10.1093/ajh/hpv049. Epub 2015 Apr 23. PMID: 25907224.
| Kinase experiment [1]: | |
|
Preparation Method |
Macrophages (enzymes) were incubated with different stimuli, alone or in the presence of the studied compounds( nor-NOHA (acetate) ) for different times. Aliquots were removed from the medium at selected times and subjected to HPLC analysis and nitrite determination. |
|
Reaction Conditions |
0.01-1000uM nor-NOHA (acetate) for 29.0min |
|
Applications |
Addition of nor-NOHA (acetate) to mouse macrophages with arginase activity cultured in medium containing L-arginine and L-[U-14C]arginine resulted in a concentration-dependent decrease in L-ornithine formation. |
| Cell experiment [2]: | |
|
Cell lines |
K562 cells |
|
Preparation Method |
K562 cells were treated with vehicle (DMSO) or increasing concentrations of nor-NOHA (acetate) (0.1 0.5 or 1mM) for 72 h, and cell viability was determined by annexin V/ 7-aad staining. |
|
Reaction Conditions |
0.1-1mM nor-NOHA (acetate) for 72h |
|
Applications |
nor-NOHA (acetate) had little effect on cell viability under normoxia, it significantly induced apoptosis in a dose-dependent manner under hypoxia, the level of intracellular arginine was reduced upon induction of ARG2 under hypoxia but was restored by nor-NOHA (acetate), confirming the inhibition of arginase activity. |
| Animal experiment [3]: | |
|
Animal models |
AIA rats |
|
Preparation Method |
AIA rats were treated with nor-NOHA (acetate) (40 mg/kg/ day, IP) for 21 days after the onset of arthritis. A group of untreated AIA rats and a group of healthy rats served as controls. |
|
Dosage form |
nor-NOHA (acetate) (40 mg/kg/d, i.p) for 21 days |
|
Applications |
nor-NOHA (acetate) treatment could fully restore the aortic response to Ach to that of healthy rats. The results also showed that such beneficial effect was mediated by an increase in NOS activity and EDHF and reduced superoxide anion production. In addition, nor-NOHA (acetate) could decrease IL-6 and VEGF plasma levels in AIA rats. Whereas, the treatment did not modify arthritis severity in AIA rats. |
|
References: [1]. Tenu JP, Lepoivre M, et,al. Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide. 1999 Dec;3(6):427-38. doi: 10.1006/niox.1999.0255. PMID: 10637120. [2]. Ng KP, Manjeri A, et,al. The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target. PLoS One. 2018 Oct 11;13(10):e0205254. doi: 10.1371/journal.pone.0205254. PMID: 30307989; PMCID: PMC6181325. [3]. Prati C, Berthelot A, et,al. Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis. Arthritis Res Ther. 2012 May 30;14(3):R130. doi: 10.1186/ar3860. PMID: 22647483; PMCID: PMC3446511. |
|
| Cas No. | 1140844-63-8 | SDF | |
| Synonyms | Nω-hydroxy-nor-Arginine | ||
| Chemical Name | 2S-amino-4-[[(hydroxyamino)iminomethyl]amino]-butanoic acid, diacetate | ||
| Canonical SMILES | N/C(N([H])CC[C@H](N)C(O)=O)=N\O.CC(O)=O.CC(O)=O | ||
| Formula | C5H12N4O3 • 2C2H4O2 | M.Wt | 296.3 |
| Solubility | ≤5mg/ml in DMSO;1mg/ml in dimethyl formamide | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.375 mL | 16.8748 mL | 33.7496 mL |
| 5 mM | 0.675 mL | 3.375 mL | 6.7499 mL |
| 10 mM | 0.3375 mL | 1.6875 mL | 3.375 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 12 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *